Anti-Aging
Sermorelin
Natural GH stimulation
This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.
About Sermorelin
Stimulates your pituitary gland to naturally produce more growth hormone.
How it works
Sermorelin is a GHRH analog that stimulates the pituitary to produce more of its own growth hormone naturally. Unlike synthetic HGH, sermorelin works with your body's existing feedback loops, making it gentler and more sustainable.
Clinical evidence
Sermorelin was developed and FDA-approved for pediatric growth hormone deficiency (Geref, 1990s) before falling out of commercial production. In adults, sermorelin has been studied as a GHRH replacement strategy for somatopause — the age-related decline in pituitary GH secretion. Walker et al. (Clin Endocrinol 1990s) demonstrated dose-dependent restoration of GH/IGF-1 in older adults. Because sermorelin works upstream at the pituitary level, it preserves the natural pulsatile pattern of GH release and physiological negative feedback, making it safer than direct HGH replacement for long-term adult use.
Benefits
Dosing
Your prescribing physician determines the right dose, schedule, and how it's administered — based on your goals, medical history, and lab work. Your personalized protocol is provided after your consultation.
Important safety information
+
Possible side effects
Do not use if you have
If you experience severe side effects, call 911 or go to your nearest emergency room.
Frequently asked about Sermorelin
Most patients notice early effects within 2-4 weeks, with full benefits building over 8-12 weeks of consistent use. Individual response varies based on your goals, baseline health, and dose.
References
- Walker RF, Cocchi D, Cella SG, et al.. Effects of GHRH on growth hormone secretion and somatic growth · Clinical Endocrinology (1990) · PMID 2120865
- Khorram O, Laughlin GA, Yen SS. Growth hormone-releasing hormone (GHRH) and GHRH analogs as therapeutic agents · Endocrine Reviews (1997) · PMID 9408740
- Vittone J, Blackman MR, Busby-Whitehead J, et al.. Long-term GHRH treatment in older adults with GH-axis decline · Journal of Clinical Endocrinology & Metabolism (1997) · PMID 9329411
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Read more about Sermorelin
Get started today
Ready to start with Sermorelin?
Free assessment. Licensed physicians. Money-back guarantee if not approved.